Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules (Q34528991)

2 August 2017

Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules (English)

1 reference

2 August 2017

1 reference

1 reference

Frédéric Lagarce

3

0 references

William Couet

object named as

William Couet

4

0 references

author name string

Sandra Peltier

1

1 reference

PubMed ID

16715372

2 August 2017

Jean-Michel Oger

2

1 reference

PubMed ID

16715372

2 August 2017

Jean-Pierre Benoît

5

1 reference

2 August 2017

25 May 2006

1 reference

2 August 2017

Pharmaceutical Research

1 reference

2 August 2017

23

1 reference

2 August 2017

6

1 reference

2 August 2017

1243-1250

1 reference

Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.

2 August 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-006-0022-2

Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-006-0022-2

Coadministration of oral cyclosporin A enables oral therapy with paclitaxel

21 January 2018

1 reference

12 December 2020

Influence of lipid nanocapsules composition on their aptness to freeze-drying

1 reference

12 December 2020

A good practice guide to the administration of substances and removal of blood, including routes and volumes

1 reference

12 December 2020

Tissue distribution of indinavir administered as solid lipid nanocapsule formulation in mdr1a (+/+) and mdr1a (-/-) CF-1 mice

1 reference

12 December 2020

A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.

1 reference

12 December 2020

Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors

1 reference

12 December 2020

Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin

1 reference

12 December 2020

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine

1 reference

12 December 2020

A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A.

1 reference

12 December 2020

Enhanced oral absorption and decreased elimination of paclitaxel in mice cotreated with cyclosporin A

1 reference

12 December 2020

New lipid nanocapsules exhibit sustained release properties for amiodarone

1 reference

12 December 2020

Paclitaxel and its formulations

1 reference

12 December 2020

Taxol: a history of pharmaceutical development and current pharmaceutical concerns

1 reference

12 December 2020

Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers

1 reference

12 December 2020

In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits

1 reference

12 December 2020

A novel phase inversion-based process for the preparation of lipid nanocarriers

1 reference

12 December 2020

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

1 reference

12 December 2020

Role of formulation vehicles in taxane pharmacology

1 reference

12 December 2020

Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031.

1 reference

12 December 2020

1 reference

12 December 2020

Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance

1 reference

12 December 2020

Comparison of solutol HS 15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents

1 reference

12 December 2020

Solid lipid nanoparticles for parenteral drug delivery.

1 reference

12 December 2020

Formulating paclitaxel in nanoparticles alters its disposition

1 reference

12 December 2020

Hepatic metabolism and biliary excretion of Taxol in rats and humans

1 reference

12 December 2020

Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats

1 reference

12 December 2020

Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation

1 reference

12 December 2020

Development of a supersaturable SEDDS (S‐SEDDS) formulation of paclitaxel with improved oral bioavailability

1 reference

12 December 2020

Clinical pharmacology of Taxol

1 reference

12 December 2020

Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts

1 reference

12 December 2020

Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.

1 reference

12 December 2020

Oral delivery of taxanes

1 reference

12 December 2020

Improvement of oral drug treatment by temporary inhibition of drug transporters and/or cytochrome P450 in the gastrointestinal tract and liver: an overview

1 reference

12 December 2020

10.1007/S11095-006-0022-2

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

16715372